Evidence map›Paper›PMID 29120352›Full record

SynthesisNutrients2017

Coffee Decreases the Risk of Endometrial Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies.

Alessandra Lafranconi, Agnieszka Micek, Fabio Galvano, Sabrina Rossetti, Lino Del Pup, Massimiliano Berretta, Gaetano Facchini

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Endometrial Cancer Staging: Is There Value in ADC?Journal of personalized medicine · 2023
    Article
  6. Article
  7. Article
  8. Coffee consumption and cancer risk: a Mendelian randomisation study.Clinical nutrition (Edinburgh, Scotland) · 2022
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Phytochemicals in Gynecological Cancer Prevention.International journal of molecular sciences · 2021
    Review
  15. A Decade of Research on Coffee as an Anticarcinogenic Beverage.Oxidative medicine and cellular longevity · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Cancer Progress and Priorities: Uterine Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alessandra LafranconiThe Research Centre on Public Health, University Milano-Bicocca, via Pergolesi 33, 20900 Monza, Italy. alessandra.lafranconi@unimib.it.
Agnieszka MicekDepartment of Epidemiology and Population Studies, Jagiellonian University Medical College, 31008 Krakow, Poland. agnieszka.micek@uj.edu.pl.
Fabio GalvanoDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania, Italy. fgalvano@unict.it.ORCID 0000-0003-0644-0755
Sabrina RossettiDivision of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy. sabrinarossetti@virgilio.it.ORCID 0000-0002-4586-9610
Lino Del PupGynecological Oncology, National Cancer Institute-IRCCS, 33081 Aviano (PN), Italy. ldelpup@cro.it.
Massimiliano BerrettaDepartment of Medical Oncology, National Cancer Institute-IRCCS, 33081 Aviano (PN), Italy. mberretta@cro.it.ORCID 0000-0002-4586-9610
Gaetano FacchiniDivision of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy. gafacchi@libero.it.ORCID 0000-0002-4586-9610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this study was to perform a comprehensive meta-analysis of the association between coffee consumption and risk of endometrial cancer.

methodsEligible studies were identified by searching the PubMed and EMBASE databases. The dose-response relationship as well as the risk of endometrial cancer for the highest versus the lowest categories of coffee consumption were assessed. Subgroup analyses considering the menopausal and receptor statuses, the smoking status, and the BMI (Body Mass Index) were performed in order to identify potential confounders.

resultsWe identified a total of 12 studies eligible for meta-analysis. A dose-response meta-analysis showed a decreased risk of endometrial cancer. Moreover, a subgroup analysis indicated that coffee consumption is significantly associated with a decreased risk of postmenopausal cancer. Increasing coffee consumption by four cups per day was associated with a 20% reduction in endometrial cancer risk (relative risk (RR) 0.80; 95% confidence interval (CI) 0.72 to 0.89) and with a 24% reduction in postmenopausal cancer risk (RR 0.76; 95% CI 0.69 to 0.83).

conclusionsOur findings suggest that increased coffee consumption is associated with decreased risk of endometrial cancer, and this association is observed also for postmenopausal cancer.

Indexed as

CoffeeDose-Response Relationship, DrugEndometrial NeoplasmsFemaleHumansPostmenopauseRisk FactorsCoffeecaffeinecoffeeendometrial cancermeta-analysispostmenopausalprospective cohort

Identifiers

PMID29120352
PMCPMC5707695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.